Utama › Jangkitan COVID-19 dan Koronavirus › New York
Kajian klinikal Jangkitan COVID-19 dan Koronavirus di New York
6 kajian untuk Jangkitan COVID-19 dan Koronavirus sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
- Columbia University Medical Center, New York
Mengambil pesertaKajian pemerhatian
Umur 7 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04448145Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Buffalo
- Research Site, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- NYU Langone Health - Brooklyn, Brooklyn
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Upstate Global Health Institute, East Syracuse
- Upstate Connect Care, Syracuse
- Prime Global Research, The Bronx
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Weill Cornell Medical College, New York
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 23 Jun 2026 · NCT03808922ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
- NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Apr 2026 · NCT04367857Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.